Relief Reports that U.S. Collaboration Partner Announces New, Favorable Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19

3 years ago

GENEVA, SWITZERLAND / ACCESSWIRE / December 15, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQBRLFTY) (" Relief "), a biopharmaceutical company…

Novo Integrated Sciences Reports Fiscal Full Year 2021 Financial Results

3 years ago

BELLEVUE, Wash.--(BUSINESS WIRE)--Novo Integrated Sciences, Inc. (NASDAQ:NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness…

Scryb Now Listed on OTCQB under “SCYRF”

3 years ago

Toronto, Ontario--(Newsfile Corp. - December 14, 2021) - Scryb Inc.  (CSE: SCYB) (OTCQB: SCYRF) (OTCQB: RYMDF) (FSE: EIY) ("Scryb" or the "Company"),…

ADVENT ENT Reports Successful Expansion During COVID-19 Pandemic

3 years ago

The ENT clinic added more surgeons and providers last year after updating their ENT software system. BOCA RATON, Fla.--(BUSINESS WIRE)--The…

Immunicom Recruits Dr. Erdal Bozdoğan to Join Leadership Team

3 years ago

Experienced healthcare marketing expert will head Immunicom’s market development in Turkey SAN DIEGO--(BUSINESS WIRE)--#biotech--Immunicom, Inc., a clinical-stage biotech pioneering non-pharmaceutical…

Cadence Raises $100 Million to Build the Infrastructure of the Future for Health Systems

3 years ago

Funding will accelerate access to virtual care for communities with chronic conditions across the U.S. NEW YORK--(BUSINESS WIRE)--Cadence, the health…

Innovative New Products and Technology Advancing Worldwide Liver Disease Management Highlight Echosens 20th Anniversary

3 years ago

PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--#FibroScan--Echosens, a high-technology company offering the FibroScan® portfolio of solutions, is pleased to celebrate its 20th…

Viveve Announces Completion of Full Enrollment in Pivotal U.S. PURSUIT Trial for Stress Urinary Incontinence

3 years ago

Major milestone achieved in Company's advance toward a new U.S. SUI indicationENGLEWOOD, CO / ACCESSWIRE / December 14, 2021 /…

Sterna Biologicals Announces Dosing of First Patient in Phase IIa Proof-of-concept Study with SB010 in Moderate to Severe Asthma

3 years ago

GIANT-1 study to evaluate once-daily oral inhalation of novel catalytic antisense oligonucleotide formulation SB010 in patients with moderate to severe…

Going Up: CLS Holdings USA, Inc. Announces November Results With Record Breaking Gross Profit Margin

3 years ago

LAS VEGAS, NV / ACCESSWIRE / December 14, 2021 / CLS Holdings USA, Inc. (OTCQB:CLSH)(CSE:CLSH), the ''Company'' or ''CLS'', a…